New shot could help shed pounds – early trial underway
NCT ID NCT06054698
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 study tested an injectable drug called HRS9531 in 61 overweight or obese adults to see if it helps with weight loss over 36 weeks. Participants received either the drug or a placebo, and researchers measured changes in body weight. The goal is to find a new treatment option for obesity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HRS9531 injection
What this could lead to
If successful, this could point toward a new injectable medication for weight loss in people who are overweight or obese.
What could go wrong
This is an early Phase 2 trial with only 61 participants, so results may not apply to everyone. The drug may cause side effects or fail to show meaningful weight loss compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Sir Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310016, China
-
The Affiliated Hospital of Xuzhou Medicine University
Xuzhou, Jiangsu, 221000, China
-
Zhejiang Hospital
Hangzhou, Zhejiang, 310007, China